Concepts (186)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cortical Spreading Depression | 5 | 2021 | 9 | 1.910 |
Why?
|
| Zinc | 4 | 2013 | 128 | 1.160 |
Why?
|
| Cortical Excitability | 1 | 2025 | 2 | 0.920 |
Why?
|
| NAV1.6 Voltage-Gated Sodium Channel | 1 | 2025 | 27 | 0.900 |
Why?
|
| Brain Stem | 2 | 2016 | 108 | 0.880 |
Why?
|
| Action Potentials | 2 | 2019 | 476 | 0.830 |
Why?
|
| Sodium | 1 | 2025 | 280 | 0.830 |
Why?
|
| Seizures | 4 | 2025 | 890 | 0.830 |
Why?
|
| Seizures, Febrile | 1 | 2023 | 32 | 0.760 |
Why?
|
| Nodose Ganglion | 1 | 2022 | 4 | 0.760 |
Why?
|
| Solitary Nucleus | 1 | 2022 | 4 | 0.760 |
Why?
|
| Cerebral Cortex | 1 | 2025 | 445 | 0.730 |
Why?
|
| KCNQ2 Potassium Channel | 1 | 2021 | 42 | 0.680 |
Why?
|
| Cation Transport Proteins | 7 | 2016 | 100 | 0.610 |
Why?
|
| Brain | 5 | 2023 | 3175 | 0.590 |
Why?
|
| Autonomic Fibers, Preganglionic | 1 | 2019 | 2 | 0.580 |
Why?
|
| Adrenergic Agonists | 1 | 2019 | 9 | 0.580 |
Why?
|
| Medulla Oblongata | 1 | 2019 | 24 | 0.570 |
Why?
|
| Periodicity | 1 | 2019 | 48 | 0.570 |
Why?
|
| Mice | 16 | 2025 | 18301 | 0.510 |
Why?
|
| Excitatory Postsynaptic Potentials | 3 | 2016 | 101 | 0.510 |
Why?
|
| Neurons | 7 | 2016 | 1979 | 0.500 |
Why?
|
| Mice, Inbred C57BL | 11 | 2021 | 4738 | 0.500 |
Why?
|
| Electroencephalography | 4 | 2025 | 863 | 0.470 |
Why?
|
| Sp1 Transcription Factor | 3 | 2016 | 39 | 0.460 |
Why?
|
| Nerve Tissue Proteins | 1 | 2021 | 1075 | 0.460 |
Why?
|
| Epilepsy | 1 | 2023 | 876 | 0.460 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 2 | 2013 | 124 | 0.440 |
Why?
|
| Animals | 21 | 2025 | 33912 | 0.440 |
Why?
|
| Death, Sudden | 1 | 2015 | 45 | 0.440 |
Why?
|
| Receptors, GABA-A | 1 | 2014 | 57 | 0.430 |
Why?
|
| Membrane Potentials | 2 | 2014 | 293 | 0.410 |
Why?
|
| Heart | 1 | 2019 | 650 | 0.410 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2016 | 242 | 0.410 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2016 | 268 | 0.410 |
Why?
|
| Dendrites | 1 | 2012 | 180 | 0.330 |
Why?
|
| Heart Arrest | 1 | 2015 | 356 | 0.320 |
Why?
|
| Stress, Physiological | 1 | 2012 | 259 | 0.320 |
Why?
|
| Cadmium | 1 | 2008 | 33 | 0.280 |
Why?
|
| CA1 Region, Hippocampal | 3 | 2014 | 68 | 0.270 |
Why?
|
| Glutathione | 1 | 2008 | 200 | 0.250 |
Why?
|
| Cholestanetriol 26-Monooxygenase | 1 | 2006 | 15 | 0.240 |
Why?
|
| Synaptic Transmission | 2 | 2020 | 299 | 0.240 |
Why?
|
| Mutation | 3 | 2016 | 6099 | 0.240 |
Why?
|
| Down-Regulation | 1 | 2008 | 645 | 0.240 |
Why?
|
| Potassium | 3 | 2023 | 263 | 0.240 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2006 | 104 | 0.230 |
Why?
|
| Gain of Function Mutation | 1 | 2025 | 115 | 0.220 |
Why?
|
| Copper | 3 | 2016 | 69 | 0.210 |
Why?
|
| Oxidation-Reduction | 3 | 2016 | 436 | 0.210 |
Why?
|
| Mice, Knockout | 5 | 2020 | 3819 | 0.200 |
Why?
|
| NAV1.1 Voltage-Gated Sodium Channel | 1 | 2023 | 15 | 0.200 |
Why?
|
| Patch-Clamp Techniques | 2 | 2014 | 271 | 0.190 |
Why?
|
| Ganglia, Autonomic | 1 | 2022 | 2 | 0.190 |
Why?
|
| Urethane | 1 | 2022 | 6 | 0.190 |
Why?
|
| Membrane Transport Proteins | 3 | 2013 | 180 | 0.190 |
Why?
|
| Carrier Proteins | 3 | 2013 | 993 | 0.180 |
Why?
|
| Vagus Nerve | 1 | 2022 | 50 | 0.180 |
Why?
|
| Membrane Proteins | 4 | 2023 | 1590 | 0.180 |
Why?
|
| In Vitro Techniques | 2 | 2013 | 808 | 0.180 |
Why?
|
| Brain Neoplasms | 2 | 2023 | 1306 | 0.180 |
Why?
|
| Bridged Bicyclo Compounds | 1 | 2021 | 5 | 0.180 |
Why?
|
| Phenylenediamines | 1 | 2021 | 29 | 0.170 |
Why?
|
| Disease Models, Animal | 3 | 2025 | 4697 | 0.170 |
Why?
|
| Integrases | 1 | 2022 | 157 | 0.170 |
Why?
|
| Anilides | 1 | 2021 | 52 | 0.170 |
Why?
|
| Carbamates | 1 | 2021 | 64 | 0.170 |
Why?
|
| Organ Culture Techniques | 1 | 2021 | 140 | 0.170 |
Why?
|
| Argininosuccinate Synthase | 2 | 2012 | 25 | 0.170 |
Why?
|
| Calcium | 3 | 2016 | 1010 | 0.170 |
Why?
|
| Hydrolases | 2 | 2012 | 61 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2012 | 188 | 0.150 |
Why?
|
| Neoplasms, Experimental | 1 | 2020 | 201 | 0.150 |
Why?
|
| Synaptic Potentials | 1 | 2019 | 14 | 0.150 |
Why?
|
| Calcium Channels, T-Type | 1 | 2019 | 16 | 0.150 |
Why?
|
| Synapses | 2 | 2013 | 425 | 0.140 |
Why?
|
| Norepinephrine | 1 | 2019 | 149 | 0.140 |
Why?
|
| Homeostasis | 2 | 2016 | 712 | 0.140 |
Why?
|
| Mice, Transgenic | 2 | 2021 | 2326 | 0.140 |
Why?
|
| Male | 9 | 2025 | 64957 | 0.140 |
Why?
|
| Sodium Channels | 1 | 2019 | 97 | 0.140 |
Why?
|
| Glioma | 1 | 2023 | 494 | 0.130 |
Why?
|
| Epinephrine | 1 | 2019 | 150 | 0.130 |
Why?
|
| Chelating Agents | 3 | 2015 | 52 | 0.130 |
Why?
|
| Female | 9 | 2025 | 70963 | 0.130 |
Why?
|
| CRISPR-Cas Systems | 1 | 2020 | 317 | 0.130 |
Why?
|
| Base Sequence | 4 | 2009 | 2730 | 0.120 |
Why?
|
| Glioblastoma | 1 | 2020 | 371 | 0.120 |
Why?
|
| Calcium Channels, N-Type | 1 | 2016 | 47 | 0.120 |
Why?
|
| Epilepsy, Absence | 1 | 2016 | 36 | 0.110 |
Why?
|
| Kv1.1 Potassium Channel | 1 | 2015 | 39 | 0.110 |
Why?
|
| Thalamus | 1 | 2016 | 93 | 0.110 |
Why?
|
| Edetic Acid | 2 | 2011 | 25 | 0.110 |
Why?
|
| Potassium Chloride | 2 | 2011 | 45 | 0.110 |
Why?
|
| GABA Antagonists | 1 | 2014 | 17 | 0.110 |
Why?
|
| GABA Agonists | 1 | 2014 | 14 | 0.110 |
Why?
|
| Ciliary Neurotrophic Factor | 1 | 2014 | 9 | 0.110 |
Why?
|
| Propofol | 1 | 2014 | 50 | 0.110 |
Why?
|
| Pyridazines | 1 | 2014 | 49 | 0.100 |
Why?
|
| Cisplatin | 1 | 2016 | 274 | 0.100 |
Why?
|
| Visual Cortex | 1 | 2016 | 125 | 0.100 |
Why?
|
| Dithionitrobenzoic Acid | 1 | 2013 | 2 | 0.100 |
Why?
|
| Ouabain | 1 | 2013 | 17 | 0.100 |
Why?
|
| Polyethylene Glycols | 2 | 2012 | 235 | 0.100 |
Why?
|
| Cations, Divalent | 1 | 2013 | 19 | 0.100 |
Why?
|
| Microdialysis | 1 | 2013 | 59 | 0.100 |
Why?
|
| Intracellular Space | 1 | 2013 | 46 | 0.100 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2015 | 821 | 0.100 |
Why?
|
| Sodium Azide | 1 | 2012 | 4 | 0.090 |
Why?
|
| tau Proteins | 1 | 2015 | 257 | 0.090 |
Why?
|
| Ethylenediamines | 1 | 2011 | 5 | 0.090 |
Why?
|
| NAD | 1 | 2012 | 52 | 0.090 |
Why?
|
| Astrocytes | 1 | 2014 | 264 | 0.090 |
Why?
|
| Parietal Lobe | 1 | 2011 | 46 | 0.090 |
Why?
|
| Glutamic Acid | 1 | 2012 | 200 | 0.090 |
Why?
|
| Promoter Regions, Genetic | 3 | 2009 | 1207 | 0.080 |
Why?
|
| DNA | 1 | 2016 | 1399 | 0.080 |
Why?
|
| Calcium Signaling | 1 | 2012 | 243 | 0.080 |
Why?
|
| Sp4 Transcription Factor | 1 | 2009 | 3 | 0.080 |
Why?
|
| Hippocampus | 2 | 2014 | 806 | 0.080 |
Why?
|
| Neuroglia | 1 | 2011 | 224 | 0.070 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2009 | 90 | 0.070 |
Why?
|
| Glutamate-Cysteine Ligase | 1 | 2008 | 6 | 0.070 |
Why?
|
| Protein Binding | 2 | 2009 | 1652 | 0.070 |
Why?
|
| Melanoma | 2 | 2012 | 931 | 0.070 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 1336 | 0.070 |
Why?
|
| Aging | 1 | 2015 | 1242 | 0.070 |
Why?
|
| DNA, Neoplasm | 1 | 2008 | 282 | 0.060 |
Why?
|
| Cell Line, Tumor | 3 | 2012 | 3748 | 0.060 |
Why?
|
| Up-Regulation | 3 | 2015 | 825 | 0.060 |
Why?
|
| Molecular Sequence Data | 2 | 2008 | 3464 | 0.060 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2009 | 2026 | 0.060 |
Why?
|
| Transfection | 1 | 2008 | 962 | 0.060 |
Why?
|
| RNA, Messenger | 2 | 2008 | 2550 | 0.060 |
Why?
|
| DNA Primers | 1 | 2006 | 599 | 0.060 |
Why?
|
| Rats | 2 | 2012 | 3370 | 0.050 |
Why?
|
| Recombinant Proteins | 1 | 2006 | 1319 | 0.050 |
Why?
|
| Immunoglobulins | 1 | 2023 | 152 | 0.050 |
Why?
|
| Neoplasms | 1 | 2015 | 3016 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2020 | 767 | 0.030 |
Why?
|
| Humans | 8 | 2023 | 131163 | 0.030 |
Why?
|
| Biological Transport, Active | 1 | 2016 | 70 | 0.030 |
Why?
|
| Motor Disorders | 1 | 2016 | 7 | 0.030 |
Why?
|
| Receptors, Neurotensin | 1 | 2016 | 6 | 0.030 |
Why?
|
| Ethosuximide | 1 | 2016 | 15 | 0.030 |
Why?
|
| Luminescent Proteins | 1 | 2016 | 142 | 0.030 |
Why?
|
| Platinum Compounds | 1 | 2015 | 5 | 0.030 |
Why?
|
| Reaction Time | 1 | 2016 | 152 | 0.030 |
Why?
|
| Biological Transport | 1 | 2015 | 329 | 0.030 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2014 | 102 | 0.030 |
Why?
|
| Cell Polarity | 1 | 2014 | 117 | 0.030 |
Why?
|
| Anticonvulsants | 1 | 2016 | 363 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2012 | 25 | 0.020 |
Why?
|
| Synaptosomes | 1 | 2012 | 19 | 0.020 |
Why?
|
| Genes, ras | 1 | 2012 | 95 | 0.020 |
Why?
|
| Protein Stability | 1 | 2012 | 165 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2012 | 136 | 0.020 |
Why?
|
| Ubiquitin | 1 | 2012 | 128 | 0.020 |
Why?
|
| Purines | 1 | 2012 | 118 | 0.020 |
Why?
|
| Neurotransmitter Agents | 1 | 2012 | 134 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2012 | 299 | 0.020 |
Why?
|
| Proteolysis | 1 | 2012 | 200 | 0.020 |
Why?
|
| Polycyclic Compounds | 1 | 2010 | 5 | 0.020 |
Why?
|
| Indicators and Reagents | 1 | 2010 | 43 | 0.020 |
Why?
|
| Hypoxia, Brain | 1 | 2010 | 34 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2012 | 700 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2012 | 300 | 0.020 |
Why?
|
| Pyramidal Cells | 1 | 2010 | 151 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2010 | 246 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2009 | 292 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2009 | 223 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2012 | 1105 | 0.020 |
Why?
|
| Brain Injuries | 1 | 2014 | 710 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2009 | 242 | 0.020 |
Why?
|
| Brain Ischemia | 1 | 2010 | 266 | 0.020 |
Why?
|
| RNA Interference | 1 | 2009 | 491 | 0.020 |
Why?
|
| Zinc Fingers | 1 | 2008 | 116 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 1205 | 0.020 |
Why?
|
| Arginine | 1 | 2009 | 340 | 0.020 |
Why?
|
| Binding Sites | 1 | 2009 | 1133 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2012 | 2885 | 0.010 |
Why?
|
| Glucose | 1 | 2010 | 853 | 0.010 |
Why?
|
| Cell Line | 1 | 2008 | 2552 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2008 | 1363 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2012 | 4686 | 0.010 |
Why?
|
| Pregnancy | 1 | 2012 | 7512 | 0.010 |
Why?
|